Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants-Reference-Cited by-同舟云学术

Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants

Published:2022-08 Issue:8 Volume:25 Page:104745
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Chiuppesi Flavia,Zaia John A.,Faircloth Katelyn,Johnson Daisy,Ly Minh,Karpinski Veronica,La Rosa Corinna,Drake Jennifer,Marcia Joan,Acosta Ann Marie,Dempsey Shannon,Taplitz Randy A.,Zhou Qiao,Park Yoonsuh,Ortega Francisco Sandra,Kaltcheva Teodora,Frankel Paul H.,Rosen Steven,Wussow Felix,Dadwal Sanjeet,Diamond Don J.^ORCID

Funder

Carol Moss Foundation

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference41 articles.

1. Effectiveness of homologous and heterologous covid-19 boosters against omicron;Accorsi;N. Engl. J. Med.,2022

2. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2;Afkhami;Cell,2022

3. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant;Andrews;N. Engl. J. Med.,2022

4. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study;Angyal;Lancet. Microbe,2022

5. SARS-CoV-2-specific T cells in infection and vaccination;Bertoletti;Cell. Mol. Immunol.,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular characterization of SARS-CoV-2 nucleocapsid protein;Frontiers in Cellular and Infection Microbiology;2024-05-23

2. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges;npj Vaccines;2024-05-23

3. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus;Communications Medicine;2024-02-16

4. Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters;Frontiers in Immunology;2023-10-18

5. Intranasal inoculation of female BALB/c mice with replication-deficient human adenovirus type 5 expressing SARS-CoV‐2 nucleocapsid protein aggravates lung pathology upon re-encountering the antigen;Virus Research;2023-10